NASDAQ$TNDM
Tandem Diabetes Care Inc · Q1 2021 earnings
Q1 2021 earnings · · Investor relations
Briefing
Reported financial results for the first quarter of 2021 and updated sales guidance for the year ending December 31, 2021.
Tandem Diabetes Care announced a strong start to 2021 with record first-quarter sales, driven by increased pump shipments and international growth. The company updated its full-year sales guidance, reflecting confidence in continued positive momentum.
- Worldwide pump shipments increased 46 percent year-over-year to 25,352 pumps.
- Sales increased 44 percent year-over-year to $141.0 million.
- Gross margin improved to 52 percent from 51 percent year-over-year.
- Operating margin improved to negative 2 percent from negative 14 percent year-over-year.
Headline financials
Revenue & EPS history
Tandem Diabetes · Revenue · Quarterly
$141M
Revenue by segment
Tandem Diabetes · $80.7M total across 1 segment · Q3 2022
- Pump Sales$80.7M—100.0%
Forward guidance
The company updated its financial guidance for the year ending December 31, 2021.
Tailwinds
- Sales are estimated to be in the range of $625 million to $640 million, representing 25% to 28% annual sales growth compared to 2020.
- International sales are projected to be approximately $125 million to $130 million, indicating 50% to 56% annual sales growth compared to 2020.
- Gross margin is estimated to be approximately 55%.
- Adjusted EBITDA is estimated to be 14% to 15% of sales.
- The company's prior sales guidance for 2021 was estimated to be in the range of $600 million to $615 million.
Headwinds
- Non-cash charges included in cost of goods sold and operating expenses are estimated to be approximately $80 million.
- Approximately $65 million in non-cash, stock-based compensation expense.
- Approximately $15 million of depreciation and amortization.
- There is substantial uncertainty associated with predicting any future adjustments that we may make to our GAAP financial measures in calculating our non-GAAP financial measures.
- The Company’s actual results may differ materially from those indicated in these forward-looking statements due to numerous risks and uncertainties.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2021
-0.4%
Avg return
Earnings day
-2.2%
Avg return
5 days after
+3.5%
Avg return
30 days after
55%
27 / 49 earnings
Positive
+32.8%
Q4 2025
Best reaction
-63.6%
Q3 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +7.6% | -23.6% | +5.0% | |
| Q4 2025 | +32.8% | +40.4% | +34.0% | |
| Q3 2025 | +22.0% | +35.5% | +56.9% | |
| Q1 2025 | +18.6% | +26.5% | +17.6% | |
| Q4 2024 | -35.2% | -42.0% | -42.6% | |
| Q3 2024 | +0.6% | -5.3% | -9.1% | |
| Q2 2024 | +12.7% | +17.3% | +17.6% | |
| Q1 2024 | +23.5% | +21.5% | +41.5% | |
| Q4 2023 | +6.1% | +22.5% | +28.4% | |
| Q3 2023 | -12.1% | -11.5% | +22.5% | |
| Q2 2023 | +2.8% | -13.4% | -14.3% | |
| Q1 2023 | -2.9% | -13.4% | -35.9% | |
| Q4 2022 | -2.1% | -8.0% | +8.0% | |
| Q3 2022 | -34.3% | -31.5% | -23.7% | |
| Q2 2022 | -14.0% | -11.8% | -34.3% | |
| Q1 2022 | -16.4% | -27.6% | -33.8% | |
| Q4 2021 | -0.3% | +7.6% | +7.6% | |
| Q3 2021 | -4.9% | -2.6% | -4.3% | |
| Q2 2021 | +4.7% | +2.6% | +8.8% | |
| Q1 2021 | -5.6% | -11.9% | -5.8% | |
| Q4 2020 | +3.5% | +4.4% | -10.0% | |
| Q3 2020 | +1.5% | -11.4% | -17.9% | |
| Q2 2020 | +1.8% | +3.0% | +10.1% | |
| Q1 2020 | +7.6% | +13.7% | +11.5% | |
| Q4 2019 | -11.4% | -15.2% | -34.7% | |
| Q3 2019 | -6.5% | -8.0% | +2.2% | |
| Q2 2019 | +2.9% | -1.5% | +14.2% | |
| Q1 2019 | -5.8% | +6.3% | +9.2% | |
| Q4 2018 | +27.9% | +43.2% | +31.8% | |
| Q3 2018 | +6.3% | -2.2% | -2.1% | |
| Q2 2018 | +7.7% | +29.0% | +59.9% | |
| Q1 2018 | +7.9% | +7.7% | +96.4% | |
| Q4 2017 | +23.1% | +25.0% | +57.0% | |
| Q3 2017 | -3.4% | -6.4% | +2.7% | |
| Q2 2017 | -17.3% | -39.4% | +8.7% | |
| Q1 2017 | -11.8% | -10.5% | -22.4% | |
| Q4 2016 | -19.1% | -10.6% | -51.1% | |
| Q3 2016 | -63.6% | -66.9% | -63.2% | |
| Q2 2016 | -13.9% | -18.8% | -8.4% | |
| Q1 2016 | +7.1% | — | — | |
| Q4 2015 | +11.9% | — | — | |
| Q3 2015 | +20.6% | — | — | |
| Q2 2015 | +8.9% | — | — | |
| Q1 2015 | +1.7% | — | — | |
| Q4 2014 | -3.1% | — | — | |
| Q3 2014 | -11.0% | — | — | |
| Q2 2014 | +11.4% | — | — | |
| Q1 2014 | -11.7% | — | — | |
| Q4 2013 | +4.0% | — | — | |
| Q2 2013 | — | — | — | |
| Q1 2013 | — | — | — | |
| Q4 2012 | — | — | — | |
| Q3 2012 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro